COMMUNIQUÉS West-GlobeNewswire

Innate pharma à la 3ème journée Oncologie de Bryan Garnier le 13 juin 2018
11/06/2018
Innate pharma à la 3ème journée Oncologie de Bryan Garnier le 13 juin 2018 Marseille le 11 juin 2018, 7h00 CEST Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 - IPH) annonce aujourd'hui qu'elle sera [...]
Bone Therapeutics SA : Information on the total number of voting rights and shares
11/06/2018
Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 11 June 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions
11/06/2018
Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 11 juin 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de [...]
Resverlogix Announces Withdrawal of Public Offering of Units
09/06/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, June 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) [...]
Adamas Announces New Employment Inducement Grant
08/06/2018
EMERYVILLE, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the compensation committee of the company’s board of directors granted six new employees the option [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/06/2018
MENLO PARK, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Tetraphase Pharmaceuticals Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08/06/2018
WATERTOWN, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy to be Presented at the 2018 Annual Cure SMA Conference on June 16, 2018
08/06/2018
SOUTH SAN FRANCISCO, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that data from the Phase 2 clinical study of reldesemtiv in patients with spinal muscular atrophy ( [...]
AxoGen Chairman and CEO Karen Zaderej Named Entrepreneur Of The Year 2018 Award Winner in Florida
08/06/2018
Award recognizes entrepreneurs who are excelling in areas such as innovation, financial performance, and personal commitment to their businesses and communities ALACHUA, Fla., June 08, 2018 (GLOBE NEWSWIRE) -- AxoGen, [...]
Positive clinical phase III results of vortioxetine in Japanese adults with Major Depressive Disorder
08/06/2018
New clinical phase III data from a study conducted in Japan demonstrate the efficacy of vortioxetine compared to placebo for the treatment of Major Depressive Disorder (MDD) in Japanese adults Positive results suggest [...]
CALSTAR Air Medical Services to Open New Air Medical Base in Santa Cruz County
08/06/2018
SANTA CRUZ, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- CALSTAR Air Medical Services, a subsidiary of REACH Air Medical Holdings, has announced that it will open a new air medical transport base in Santa Cruz County [...]
Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 41st European Cystic Fibrosis Conference (ECFS)
08/06/2018
ELX-02 demonstrated dose-dependent rescue of CFTR function in human bronchial epithelial cells (HBEs) and organoids from patients carrying at least one nonsense CFTR mutation Eloxx expects to initiate a Phase 2 clinical [...]
Solon Eiendom ASA : Preliminary result of the subsequent offering
08/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Cannabis Wheaton Income Corp. Announces Name Change to Auxly Cannabis Group Inc.
08/06/2018
VANCOUVER, British Columbia, June 08, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to announce that it has changed its corporate name from “Cannabis Wheaton [...]
NHL player Max Domi teams up with thousands of Torontonians to walk to find a cure for type 1 diabetes
08/06/2018
The Sun Life Walk to Cure Diabetes for JDRF aims to raise $5.4M to accelerate research TORONTO, June 08, 2018 (GLOBE NEWSWIRE) -- NHL player, Max Domi will be walking at the Sun Life Walk to Cure Diabetes for JDRF’s [...]
Oncobiologics Closes Second Tranche of $15 Million Private Placement
08/06/2018
CRANBURY, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (the “Company”) today announced that it has closed on the second, and final, tranche of a $15.0 million private placement of shares of [...]
ADMA Biologics Announces Pricing of Public Offering of Common Stock
08/06/2018
RAMSEY, N.J. and BOCA RATON, Fla., June 08, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”) announced today the pricing of its previously announced underwritten public offering of 8 [...]
Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
08/06/2018
BOSTON, June 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the election of Anne Klibanski [...]
Zealand Pharma achieves milestone in first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes
08/06/2018
Press release - No. 15/2018 Zealand Pharma achieves milestone in first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes The results of the first of two completed Phase 3 trials [...]

Pages